Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00728429 · ClinicalTrials.gov registry record · NA
Aerobic Exercise in Patients Receiving Chemotherapy for Cancer
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT00728429 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 1 participants.
The verdict
NCT00728429, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
RATIONALE: Aerobic exercise may help prevent side effects caused by chemotherapy and help improve heart health. PURPOSE: This randomized clinical trial is studying the side effects of aerobic exercise and to see how well it works in patients receiving chemotherapy for cancer.
Interventions
- BEHAVIORAL exercise intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00728429
The ClinicalTrials.gov registry entry for NCT00728429 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which exercise intervention is the first listed.
NCT00728429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00728429 about?
NCT00728429 is a clinical study titled "Aerobic Exercise in Patients Receiving Chemotherapy for Cancer". RATIONALE: Aerobic exercise may help prevent side effects caused by chemotherapy and help improve heart health. PURPOSE: This randomized clinical trial is studying the side effects of aerobic exercise and to see how well it works in patients receiving chemotherapy for cancer.
What is the current status of trial NCT00728429?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2008-06. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00728429?
The interventions under investigation include: exercise intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00728429?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.